Abstract

BackgroundTicks are the most important vectors of disease-causing pathogens in domestic animals and are considered to be second worldwide to mosquitoes as vectors of human diseases. In Europe, Ixodes ricinus, the sheep tick, plays an important role as companion animal parasite but is also the primary vector of medically important diseases such as tick-borne encephalitis and Lyme borreliosis.The present study was designed to evaluate the efficacy under laboratory conditions of a new fixed spot-on combination of fipronil and permethrin (Effitix®, Virbac) in treating and preventing tick infestations of Ixodes ricinus in dogs.MethodsTwelve dogs were included in this randomized, controlled, blinded laboratory study. They were randomly allocated to two groups of six dogs each according to their pre-treatment live attached Ixodes ricinus tick count. On day 0, the dogs from Group 2 were treated with the recommended dose of Effitix®, the dogs from Group 1 remained untreated. On days −2, 7, 14, 21, 28 and 35, all dogs were infested with 50 (±4) viable unfed adult Ixodes ricinus (20 ± 2 males, 30 ± 2 females). Ticks were removed and counted at 48 ± 2 hours post product administration or tick infestations.ResultsThrough the study, the tick attachment rates for the untreated group were greater than 25% demonstrating that adequate levels of infestation were reached on the control dogs. Based on both arithmetic and geometric means (AM and GM), Effitix® was deemed to be effective against Ixodes ricinus on days 2, 9, 16, 23, 30 and 37 with a percentage of efficacy of 98%, 100%, 100%, 100%, 93% and 95% respectively (AM). No clinical abnormalities were detected during the study.ConclusionsThe study has shown under laboratory conditions, that Effitix® is a safe and an effective combination to treat and protect dogs from Ixodes ricinus up to 37 days after administration. The high immediate efficacy of 98% evaluated at 48 hours post-treatment was particularly interesting, meaning that Effitix has a curative effect against ticks (Ixodes ricinus) and provides a rapid control of existing Ixodes ricinus infestation on a dog at the time of treatment.

Highlights

  • Ticks are the most important vectors of disease-causing pathogens in domestic animals and are considered to be second worldwide to mosquitoes as vectors of human diseases

  • Tick attachment rates The results (Table 2) show that the experimental infestations with I. ricinus were successful, with retention rates on the control untreated dogs ranging between 55% and 71% providing a severe challenge to assess the acaricidal effect of the combination product

  • The artificial infestation model with I. ricinus used for this study provided a challenge to assess the Effitix® acaricidal effect compared to natural conditions

Read more

Summary

Introduction

Ticks are the most important vectors of disease-causing pathogens in domestic animals and are considered to be second worldwide to mosquitoes as vectors of human diseases. In Europe, Ixodes ricinus, the sheep tick, plays an important role as companion animal parasite but is the primary vector of medically important diseases such as tick-borne encephalitis and Lyme borreliosis. In Europe, Ixodes ricinus (Acari: Ixodidae) known as the sheep tick or the castor bean tick, is the primary vector of medically important disease agents like the tick-borne encephalitis complex of viruses, the Borrelia burgdorferi sensu lato complex, the causative agents of Lyme borreliosis, Rickettsia, Babesia, and Anaplasma species [2]. Other ecological changes such as how we manage habitats, the distribution and abundance of tick hosts and/or the increasing initiatives to create natural environments and the trend towards spending more time in nature for recreational activities are important considerations, leading to an increased risk of disease caused by these pathogens, in particular of Lyme borreliosis [3,4,5]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call